Global Vitamin D Therapy Market – Industry Trends and Forecast to 2029

Global Vitamin D Therapy Market, By Application (Osteoporosis, Rickets, Autoimmune Disorder, Skin Diseases, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.

Vitamin D Therapy Market Analysis and Size

The deficiency of essential vitamins such as vitamin D has been one of the most common problems witnessed in the past few years because of the sedentary lifestyles that can lead to lesser exposure to sun resultant skin diseases, muscle weakness and bone pain driving the market. Among the vitamin D compounds, Vitamin D2 /ergocalciferol and vitamin D3 /cholecalciferol are considered to be crucial for humans.

Data Bridge Market Research analyses a growth rate in the global vitamin D therapy market in the forecast period 2022-2029. The expected CAGR of global vitamin D therapy market is tend to be around 12.1% in the mentioned forecast period. The market was valued at USD 2.39 billion in 2021, and it would grow upto USD 5.96 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Vitamin D Therapy Market Scope and Segmentation

Market Definition

Vitamin D is a group of fat-soluble secosteroids which are present only in some foods that are essential for the intestinal absorption of calcium, phosphate, and magnesium. When the skin is exposed to sunlight, it activates the synthesis of vitamin D from cholesterol. Deficiency of vitamin D can lead to poor exposure to sunlight rays, malabsorption, sedentary lifestyles and accelerated catabolism from certain drugs. This deficiency causes muscle weakness and bone pain. Thus, Vitamin D therapy is given in various bone related disorders.            

Global Vitamin D Therapy Market Dynamics

Drivers

• Increased Healthcare Expenditure

An increased incidence of malnutrition cases such as osteoporosis and rickets among all the age groups in recent years has increased the awareness programs and healthcare expenditure by the government authorities globally. For instance, according to the (CDC) Centers for Disease Control and Prevention report, in 2018, around USD 3.65 trillions of national health care expenditure was incurred by the U.S., which is projected to increase throughout the forecast period providing better opportunities to research activities and manufacturers driving the global vitamin D therapy market. 

• Rising Demand of Oral Drugs

The growing demand for oral drugs is helping boost the market's growth. This dominance is due to the ease of administration, safety, efficiency, reduced chances of toxicity coupled with patient compliance, and preference for the oral route because of the  availability in various forms like chewing gums and tablets, driving the global market.

Opportunities

• Increasing Demand for Retail Pharmacies

The rise in the number of rhinitis therapeutics delivered through the retail pharmacies and the rise in the number of these pharmacies in developed countries create opportunities for the market growth. Additionally, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.

• Higher Use of Vitamin D in Osteoporosis

The increasing use of vitamin D in different treatments such as osteoporosis, rickets, skin diseases, and autoimmune disorders is creating many opportunities for its growth. The rising incidence of falls and fractures in senior adults because of the elevated levels of parathyroid hormones re increasing the consumption of vitamin D.

 Restraints/Challenges

• Lack of skilled professionals

The lack of qualified healthcare professionals who cannot treat these patients with appropriate treatments could curb the growth of the global vitamin D therapy market over a forecast period.

This global vitamin D therapy market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global vitamin D therapy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Vitamin D Therapy Market Scope

The vitamin D therapy market is segmented on the basis of aplication, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Application

• Osteoporosis
• Rickets
• Autoimmune Disorder
• Skin Diseases
• Others

Route of Administration

• Oral
• Parenteral
• Others

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Vitamin D Therapy Market Regional Analysis/Insights

The global vitamin D therapy market is analyzed and market size insights and trends are provided by application, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global vitamin D therapy market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific has been witnessing a positive growth for global vitamin D therapy market throughout the forecasted period due to the developing healthcare facilities and large number of generic manufacturers.

North America dominates the market due to the global leaders in research and development activities, the vulnerable osteoporosis population, the presence of refined healthcare infrastructure and increase in cases of osteoarthritis.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Vitamin D Therapy Market Share Analysis

The global vitamin D therapy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global vitamin D therapy market

Key players operating in the global vitamin D therapy market include:

• Pfizer Inc.(U.S.)
• Merck KGaA (Germany)
• Sanofi (France)
• Biocare Medical, LLC (U.S.)
• Teva Pharmaceutical Industries (Israel)
• Mitsubishi Chemical Group Corporation (U.S.)
• Bristol-Myers Squibb Company (U.S.)
• GSK plc. (U.K.)
• Bayer AG (Germany)
• Teva Pharmaceuticals Industries Ltd. (Israel)
• Lilly (U.S.)
• AstraZeneca (U.K.)
• Regeneron Pharmaceuticals Inc (U.S.)
• OptiNose US, Inc (U.S.)